The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Dollar fails dope test

Most readers know that I am a keen cyclist. But, professional cycling’s reputation has been tarnished by the issue of performance enhancing drugs.

Of course, I’m all favour of clean sport, but much of the debate is a little hypocritical – after all professionals in many other walks of life can often take whatever they want without sanction if it improves their output. I’m referring to musicians and artists of course, not FX dealers.

But there is a link. Much has been done in recent years to erase drug taking in sport, especially by an organisation called the World Anti-Doping Agency (Wada). The agency is led by controversial Canadian lawyer Dick Pound. Wada is engaged in a chemical arms race – constantly perfecting a test for one performance-enhancing drug before athletes move on to the next wonder pill. According to a report on Bloomberg, however, Wada might now have to cut back on its research and stop out-of-competition testing next year. The reason is not because of legal challenges by athletes, but because of the weakness in the dollar.

Wada is based in Montreal, but it is funded in dollars by the International Olympic Committee and governments worldwide.

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.


Unlimited access to and

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually


Unlimited access to and, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors


Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree